(MENAFN- America News Hour) U.S. therapeutic nuclear medicine market
is projected to account for significant revenue share of the global therapeutic
nuclear medicine industry revenue from 2019 to 20025. Presence of suitable
facilities for development and assessment of nuclear medicine therapy will accelerate
the business growth. The U.S. market comprises vast patient population
suffering from cancer, thyroid and blood disorders that will create attractive
demand for nuclear medicine therapy. Moreover, presence of key competitors in
the country, the industry will influence the U.S. therapeutic nuclear medicine
market growth over the estimated years.
Europe therapeutic nuclear medicine
industry will advance at momentous pace on account of growing patient
population suffering from chronic ailments along with adoption of high-quality
therapeutic technology. Numerous associations including the European
Association of Nuclear Medicine are undertaking projects to develop nuclear
medicine, involving radionuclide therapy along with other areas. Furthermore,
rapid capitalization on radionuclide therapeutics by European countries will
boost therapeutic nuclear medicine business growth in Europe.
Request for a Sample
of this research report : https://www.gminsights.com/request-sample/detail/4454
Therapeutic Nuclear Medicine market report provides a comprehensive landscape of
the industry, accurate market estimates and forecast split by product,
application, technology, region and end-use. All quantitative information is
covered on a regional as well as country basis. The report provides valuable
strategic insights on the Therapeutic Nuclear Medicine market, analyzing in
detail industry impact forces including growth drivers, pitfalls and regulation
evolution. The report also includes a detailed outlook on the Therapeutic
Nuclear Medicine market competitive environment, diving into the industry
position of each major company along with the strategic landscape.
Therapeutic Nuclear Medicine market report is an all-inclusive document,
compiled and designed to provide best-in-class research, insightful analysis
and accurate quantitative data. The coverage of this research is the most
extensive when compared to other similar studies available on Therapeutic
Nuclear Medicine market. The industry ecosystem information presented in this
report is next-to-none and aims to address all stakeholders of the industry,
irrespective of their size and business function. Details of segmentation and
cross reporting structure, wherever feasible, makes this Therapeutic Nuclear
Medicine market research one of its kind to offer the most in-depth, readily
available data.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/4454
Therapeutic Nuclear
Medicine Market, By Radionuclide Type, 2014-2025 (USD Million)
- Alpha
Emitters
- Radium-223
(RA-223) & Alpharadin
- Actinium-225
(AC-225)
- Lead-212
(PB-212)/Bismuth-212 (BI-212)
- Astatine-211
(AT-211)
- Radium-224
(RA-224)
- Thorium-227
(TH-227)
- Beta
Emitters
- Iodine-131
(I-131)
- Yttrium-90
(Y-90)
- Samarium-153
(SM-153)
- Rhenium-186
(RE-186)
- Lutetium-177
(LU-177)
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
Therapeutic Nuclear Medicine Market,
By Indication, 2014-2025 (USD Million)
- Thyroid
disorders
- Cancer
- Prostate
cancer
- Breast
cancer
- Lymphoma
- Lung
cancer
- Liver
cancer
- Others
- Blood
disorders
- Bone
pain treatment
- Others
Therapeutic Nuclear Medicine Market,
By End-use, 2014-2025 (USD Million)
- Hospitals
- Ambulatory
Centers
- Cancer
Centers
- Others
Browse Report Summary: https://www.gminsights.com/industry-analysis/therapeutic-nuclear-medicine-market
Eckert &
Ziegler, Jubilant Pharma, Advanced Accelerator Applications and Progenics
Pharmaceuticals are some of the major market players involved in the global therapeutic
nuclear medicine market. These players are undertaking product innovation and
acquisition strategies to advance in the global market. In October 2017,
Novartis announced about its plan to acquire Advanced Accelerator Applications,
aimed at enhancing Novartis' product portfolio for tumor treatment.
Related Reports:
Telemedicine Cart
Market: https://www.marketwatch.com/press-release/telemedicine-cart-market-size-2020-outlook-opportunity-and-demand-analysis-report-by-2026-2020-01-21
U.S. Telemedicine
Market: https://www.marketwatch.com/press-release/us-telemedicine-market-size-2019-application-and-future-forecast-by-2025-2019-11-20
About Global Market Insights:
Global Market Insights,
Inc., headquartered in Delaware, U.S., is a global market research and
consulting service provider; offering syndicated and custom research reports
along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market
data specially designed and presented to aid strategic decision making. These
exhaustive reports are designed via a proprietary research methodology and are
available for key industries such as chemicals, advanced materials, technology,
renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]
Web: www.gminsights.com/
Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
MENAFN22012020007010068ID1099588660
-MENAFN22012020007010068ID1099588660-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.